14
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Effect of loracarbef on the normal oropharyngeal and intestinal microflora

, &
Pages 255-260 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kristian Roos & Peter Larsson. (1997) Loracarbef versus Phenoxymethylpenicillin in the Treatment of Recurrent Streptococcal Pharyngotonsillitis. Scandinavian Journal of Infectious Diseases 29:2, pages 141-145.
Read now
Marianne Floor, Frank Van Akkeren, Maja Rozenberg-Arska, Maarten Visser, Ad Kolsters, Henriëtte Beumer & Jan Verhoef. (1994) Effect of Loracarbef and Amoxicillin on the Oropharyngeal and Intestinal Microflora of Patients with Bronchitis. Scandinavian Journal of Infectious Diseases 26:2, pages 191-197.
Read now

Articles from other publishers (13)

Petra Zimmermann & Nigel Curtis. (2019) The effect of antibiotics on the composition of the intestinal microbiota - a systematic review. Journal of Infection 79:6, pages 471-489.
Crossref
Philip Toltzis, Michael Dul, Mary Ann O'Riordan, Hasida Toltzis & Jeffrey L. Blumer. (2007) Comparative Effects of Single-Dose Ceftriaxone Versus Three Oral Antibiotic Regimens on Stool Colonization by Resistant Bacilli in Children. Pediatric Infectious Disease Journal 26:1, pages 25-30.
Crossref
Åsa Sullivan & Carl Nord. 2006. Gastrointestinal Microbiology. Gastrointestinal Microbiology 335 369 .
A. Bryskier & M. Lebel. 2005. Antimicrobial Agents. Antimicrobial Agents 222 268 .
Åsa Sullivan, Charlotta Edlund & Carl Erik Nord. 2005. Antimicrobial Agents. Antimicrobial Agents 1357 1370 .
Åsa Sullivan, Charlotta Edlund & Carl Erik Nord. (2001) Effect of antimicrobial agents on the ecological balance of human microflora. The Lancet Infectious Diseases 1:2, pages 101-114.
Crossref
F. Vogel, H.R. Ochs, K. Wettich, S. Kaiich, I. Nihson-Ehle, I. Odenholt & C.E. Nord. (2001) Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia. Clinical Microbiology and Infection 7:7, pages 376-379.
Crossref
Daniel S. Sitar, Daryl J. Hoban & Fred Y. Aoki. (2013) Pharmacokinetic Disposition of Loracarbef in Healthy Young Men and Women at Steady State. The Journal of Clinical Pharmacology 34:9, pages 924-929.
Crossref
C.E. Nord. (1993) The effect of antimicrobial agents on the ecology of the human intestinal microflora. Veterinary Microbiology 35:3-4, pages 193-197.
Crossref
Rex W. Force & Milap C. Nahata. (2016) Loracarbef: A New Orally Administered Carbacephem Antibiotic. Annals of Pharmacotherapy 27:3, pages 321-329.
Crossref
Michael L. Zeckel. (1992) Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: Results of U.S. and European comparative clinical trials. The American Journal of Medicine 92:6, pages S58-S64.
Crossref
Donald G. Therasse. (1992) The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections. The American Journal of Medicine 92:6, pages S20-S25.
Crossref
Karl A. DeSante & Michael L. Zeckel. (1992) Pharmacokinetic profile of loracarbef. The American Journal of Medicine 92:6, pages S16-S19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.